Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: bc019fd1967e192cd6dc800538b304392ba1e7ad
First added on: Mar 01, 2025